Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
6.
Arch. Soc. Esp. Oftalmol ; 93(12): 606-609, dic. 2018. ilus
Artigo em Espanhol | IBECS | ID: ibc-175155

RESUMO

CASO CLÍNICO: Un varón de 70 años, procedente de Sicilia, acude con una masa palpebral bilateral con afectación tarsal conjuntival, que resultó ser un sarcoma de Kaposi al examen histológico. Se demostró afectación cutánea y pulmonar por el sarcoma de Kaposi. El paciente no tenía un diagnóstico previo de infección por el virus de la inmunodeficiencia humana. Este caso fue tratado con éxito tras 5 ciclos de quimioterapia con doxorrubicina liposomal, con resolución de las lesiones palpebrales, cutáneas y pulmonares. Conclusiones: La localización en el párpado es una posible manifestación inicial, aunque rara, del sarcoma de Kaposi en personas de edad avanzada negativos para el virus de la inmunodeficiencia humana. La doxorrubicina liposomal es un tratamiento seguro y efectivo


CASE REPORT: We report a case of 70-year-old male from Sicily, who presented with a bilateral eyelid mass involving the tarsal conjunctiva, found to be Kaposi's sarcoma on histologic examination. Cutaneous and pulmonary Kaposi's sarcoma involvement was documented. The patient had no prior diagnosis of human immunodeficiency virus infection. This case was managed successfully after the completion of five cycles of chemotherapy with liposomal doxorubicin, and his eyelid, skin and pulmonary lesions disappeared. CONCLUSIONS: Location in the eyelid is a possible, though rare, initial solitary manifestation of Kaposi's sarcoma in elderly HIV-negative patients. Liposomal doxorubicin is a safe and effective treatment


Assuntos
Humanos , Masculino , Idoso , Sarcoma de Kaposi/complicações , Doenças Palpebrais/patologia , Doxorrubicina/uso terapêutico , Acuidade Visual , Biópsia , Soronegatividade para HIV , Túnica Conjuntiva/patologia , Pálpebras/patologia , Diagnóstico Diferencial , Imuno-Histoquímica , Ensaio de Imunoadsorção Enzimática , Western Blotting , Sarcoma de Kaposi/diagnóstico por imagem , Sarcoma de Kaposi/terapia
9.
Arch Soc Esp Oftalmol (Engl Ed) ; 93(12): 606-609, 2018 Dec.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-30055902

RESUMO

CASE REPORT: We report a case of 70-year-old male from Sicily, who presented with a bilateral eyelid mass involving the tarsal conjunctiva, found to be Kaposi's sarcoma on histologic examination. Cutaneous and pulmonary Kaposi's sarcoma involvement was documented. The patient had no prior diagnosis of human immunodeficiency virus infection. This case was managed successfully after the completion of five cycles of chemotherapy with liposomal doxorubicin, and his eyelid, skin and pulmonary lesions disappeared. CONCLUSIONS: Location in the eyelid is a possible, though rare, initial solitary manifestation of Kaposi's sarcoma in elderly HIV-negative patients. Liposomal doxorubicin is a safe and effective treatment.


Assuntos
Antibióticos Antineoplásicos/uso terapêutico , Doxorrubicina/análogos & derivados , Neoplasias Palpebrais/tratamento farmacológico , Neoplasias Primárias Múltiplas/tratamento farmacológico , Sarcoma de Kaposi/tratamento farmacológico , Idoso , Doxorrubicina/uso terapêutico , Neoplasias Palpebrais/diagnóstico por imagem , Soronegatividade para HIV , Humanos , Masculino , Neoplasias Primárias Múltiplas/diagnóstico por imagem , Polietilenoglicóis/uso terapêutico , Indução de Remissão , Sarcoma de Kaposi/diagnóstico por imagem , Tomografia Computadorizada por Raios X
11.
J Fr Ophtalmol ; 41(4): 326-332, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29681466

RESUMO

INTRODUCTION: To determine outcomes of conjunctival autograft attached with fibrin glue (FG) for primary pterygium, and compare these outcomes in expert versus closely supervised trainee ophthalmologists. METHODS: This was a retrospective, comparative, non-randomized, interventional study. Patients were recruited among those with primary nasal pterygium undergoing FG conjunctival autograft. Surgery was performed by expert (136 eyes) or closely supervised trainee (128 eyes) ophthalmologists. Mean follow-up was 7.82±8.23months. Main outcome measures were recurrence rate, reoperation rate and complications. RESULTS: The study sample comprised 264 eyes of 225 patients. Participants were of mean age 47.09±12.89years; 46.7% were male, 28.4% Caucasian and 70.5% Hispanic. Recurrence was recorded in 6.4%: 5.9% in the expert group and 7% in the trainee group (P=0.704) and reoperation in 1.9%: 0.7% and 3.1% (P=0.202), respectively. Both groups showed similar rates of complications such as transient graft edema, graft dehiscence, hematoma or ocular hypertension. Reoperation was slightly more frequent in patients younger than 40years (P=0.064). CONCLUSIONS: Good outcomes were observed for FG conjunctival autografting in primary pterygium surgery, with no differences recorded between supervised trainee and expert surgeons. Our findings suggest the need to supervise pterygium surgeries during training.


Assuntos
Túnica Conjuntiva/transplante , Adesivo Tecidual de Fibrina/uso terapêutico , Oftalmologistas/educação , Pterígio/cirurgia , Transplante Autólogo/métodos , Adulto , Idoso de 80 Anos ou mais , Autoenxertos , Feminino , Seguimentos , Humanos , Curva de Aprendizado , Masculino , Pessoa de Meia-Idade , Organização e Administração , Complicações Pós-Operatórias/epidemiologia , Recidiva , Reoperação/estatística & dados numéricos , Estudos Retrospectivos , Resultado do Tratamento , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...